Menu Search
Equities

China Resources Pharmaceutical Group Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
640:STU

China Resources Pharmaceutical Group Ltd

Actions
  • Price (EUR)0.49
  • Today's Change0.002 / 0.41%
  • Shares traded0.00
  • 1 Year change-24.03%
  • Beta0.4493
Data delayed at least 15 minutes, as of Feb 10 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

China Resources Pharmaceutical Group Ltd is an investment holding company principally engaged in the pharmaceutical business. The Company operates its business through four segments. The Pharmaceutical Business segment develops, manufactures and sells a range of pharmaceuticals and health products. The Pharmaceutical Distribution Business segment provides distribution, warehousing, logistics and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers, device manufacturer and dispensers, including hospitals, distributors and retail pharmacies. The Pharmaceutical Retail Business segment operates retail pharmacies. The Other Business Operations segment engages in property holding and other businesses.

  • Revenue in HKD (TTM)293.83bn
  • Net income in HKD3.18bn
  • Incorporated2007
  • Employees86.00k
  • Location
    China Resources Pharmaceutical Group LtdRoom 4104-05, 41F,China Resources BuldngNo. 26, Harbour Road, Wan Chai Hong KongHKG
  • Phone+852 25938991
  • Fax+852 25938992
  • Websitehttps://www.crpharm.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.